The MPS Scientific Programme Committee welcome the submission of original contributions for poster presentations at the16th International Symposium on MPS and Related Diseases.
Abstract submission dates:
From January 16 to March16, 2020
When entering the abstract submission system for the first time, you will be asked to create a profile. Through your account you will be able to access your personal page where you can submit one or several abstracts. You can edit your abstracts until the submission deadline, May 16, 2020.
Instructions for authors
Carefully read the guidelines below before submitting your abstract. Acknowledgement of the receipt of each submission will be sent to the corresponding author’s e-mail address immediately upon submission. If you do not receive the confirmation e-mail, please do not submit the abstract again. Instead, please contact Agora Events at email@example.com for advice.
Abstract Submission Guidelines
Abstract structure and content
In order to make the abstract as informative as possible, please include a brief statement of the purpose of the study and/or the underlying hypotheses, the methods used, the results observed, and the conclusions based upon the results. You may subtitle the paragraphs in the following order: Background, Method, Results, and Conclusion.
The abstract title and body text should only include pharmacopoeia names printed in lower case. Trade names are not allowed. Non-proprietary (generic) names of drugs, written in lower case, are required the first time a drug is mentioned in the text. References, credits or the authors’ academic degrees or grant support are not to be included in the abstract. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording the first time it appears in the body of the text. Company names are not allowed in the title but can be named in the authors’ affiliation.
Consent for publication of individual patient data applies to abstracts with identifiable patient information
For the publication of an abstract that contains identifiable information about patients, it is necessary that patients have given consent for the research to be published. For all abstracts that include identifiable patient details (e.g. gender, age, illness, location) written informed consent for their publications must be obtained from the patient (or their parent or legal guardian).
It is the author’s responsibility to obtain written informed consent for the publication of clinical details and/or clinical images from the patient/parent/guardian/relative of the patient. A respective statement needs to be included in the abstract text.
Declaration of conflict of interest
MPS is committed to ensuring the integrity of its scientific, educational, and research programmes. Abstract submission requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict. The submitter is responsible for obtaining disclosure information from all co-authors, to be entered in the author section of the submission page.
Accepted abstracts selected by expert reviewers can be presented in any of the following sessions: Poster Session and Oral Session.
It is the author’s responsibility to submit a correct abstract. Any mistake in spelling, grammar or scientific facts will be reproduced as typed by the author as no editing will be done by MPS.
Please note that the final decision regarding the allocation and the type of presentation assigned to the submitted abstract will be made by the Scientific Programme Committee.
The Poster Session will be displayed in a designated area at the public exhibition area and will allow the presentation of your work in paper format. Specific guidelines will be provided. If you require so, you can request to have your poster printed locally. You can contact Agora Events for more information.
The Oral Sessions will have two presenting opportunities: “Hot Topics & Late Breaking News” and “Best Oral Posters”. If your poster has been selected for one of these sessions, you will be contacted by mid-May 2020.
The time allocated for presentation will be determined by the number of posters selected. As a speaker you will be required to prepare a PowerPoint presentation featuring the main findings of your work. Specific guidelines will be provided.
Notification of acceptance
Notifications of acceptance or rejection of the abstracts will be sent to the presenting author of the abstract by Mid-May 2020.
The presenting author will receive all correspondence concerning the abstract and is responsible for informing all co-authors of the status of the abstract.
With the notification of acceptance, abstract presenters will be informed about the time and date of their presentation and will be asked to reconfirm their attendance.
Publication of abstracts
The abstracts selected for Poster Session or Oral presentation by the Scientific Committee will be compiled to be published in an Abstract book of the 16th International Symposium on MPS and Related Diseases.
Please contact the Agora Events at firstname.lastname@example.org for any enquiries about abstracts submission.
Deadlines are subject to change.